farnesol has been researched along with gefarnate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamaru, H; Nakatsuka, I; Nishioka, K | 1 |
| Katagiri, T; Kizaki, M; Miyazawa, K; Nishimaki, J; Tohyama, K; Toyama, K; Yaguchi, M | 1 |
| DA CUNHA, M; GALPER, E; GOUVEIA, OF; TEIXEIRA, D | 1 |
3 other study(ies) available for farnesol and gefarnate
| Article | Year |
|---|---|
An improved method for 14C-labelling of farnesylacetic acid and its geranyl ester.
Topics: Carbon Radioisotopes; Farnesol; Gefarnate; Isotope Labeling; Terpenes | 1988 |
Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid.
Topics: Apoptosis; Bone Marrow; Diterpenes; Drug Synergism; Farnesol; Flow Cytometry; Gefarnate; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Molecular Structure; Myelodysplastic Syndromes; Structure-Activity Relationship; Tretinoin; Tumor Cells, Cultured; Vitamin K; Vitamin K 1; Vitamin K 2 | 1997 |
[THERAPY OF PEPTIC ULCER WITH GEFARNATE, GERANYL FARNESYL ACETATE].
Topics: Drug Therapy; Farnesol; Gefarnate; Humans; Peptic Ulcer; Terpenes | 1965 |